Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||
| Cash from operating activities | 130.63%379.74K | -828.74%-1.24M | 176.80%170.11K | -94.57%61.46K | 230.83%1.13M | -242.90%-864.73K | 0.96%605.14K | 599.39K |
| Net profit before non-cash adjustment | -908.15%-7.81M | 25.29%966.31K | 225.93%771.23K | 74.20%-612.44K | -221.77%-2.37M | -1.88%1.95M | 462.89%1.99M | --352.95K |
| Total adjustment of non-cash items | 409.72%6.56M | 6.54%1.29M | 18.46%1.21M | -49.57%1.02M | 265.70%2.02M | 114.83%552.76K | 42.76%257.3K | --180.24K |
| -Depreciation and amortization | 14.33%1.08M | 7.72%941.97K | 7.22%874.5K | 96.39%815.61K | 161.12%415.29K | 3.01%159.05K | 13.94%154.39K | --135.5K |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | ---48.7K | --0 | 434.88%1.29M | 667.48%241.4K | --31.45K | --0 |
| -Assets reserve and write-off | 3,910.97%5.05M | -271.03%-132.45K | 56.86%-35.7K | ---82.75K | ---- | ---- | ---- | ---- |
| -Share of associates | -78.80%31.39K | 134.90%148.08K | --63.04K | --0 | --119.88K | ---- | ---- | ---- |
| -Disposal profit | 57.70%-18.08K | -1,641.85%-42.75K | 90.21%-2.45K | 63.17%-25.05K | ---68.02K | ---- | ---- | ---- |
| -Net exchange gains and losses | ---- | ---- | ---- | ---- | --5K | ---- | ---- | ---- |
| -Other non-cash items | 13.09%420.44K | 4.14%371.78K | 14.55%356.98K | 20.72%311.63K | 69.47%258.14K | 113.17%152.32K | 59.73%71.45K | --44.74K |
| Changes in working capital | 146.69%1.63M | -93.09%-3.49M | -423.48%-1.81M | -123.29%-345.53K | 144.06%1.48M | -105.44%-3.37M | -2,575.77%-1.64M | --66.2K |
| -Change in receivables | 274.99%2.57M | 44.96%-1.47M | -40.74%-2.67M | -265.39%-1.9M | 144.82%1.15M | -160.80%-2.56M | -17.57%-980.7K | ---834.11K |
| -Change in inventory | --0 | 200.00%9.93K | ---9.93K | --0 | ---- | ---- | ---- | ---- |
| -Change in payables | 40.79%-1.1M | -370.63%-1.86M | -35.49%687.45K | -6.02%1.07M | 303.53%1.13M | -385.74%-557.1K | -45.03%194.97K | --354.7K |
| -Changes in other current assets | 193.57%162.23K | -195.28%-173.38K | -62.45%181.97K | 160.84%484.64K | -215.84%-796.53K | 70.44%-252.19K | -256.37%-853.16K | --545.61K |
| Dividends paid (cash flow from operating activities) | ||||||||
| Dividends received (cash flow from operating activities) | ||||||||
| Interest paid (cash flow from operating activities) | -15.67%-356.78K | -101.49%-308.46K | -114.09%-153.09K | -59.83%-71.51K | -44.74K | |||
| Interest received (cash flow from operating activities) | 6K | 0 | -10.27%45.15K | 6,468.80%50.32K | 1,401.96%766 | 1,175.00%51 | 4 | |
| Tax refund paid | -10.44%-416.3K | -98.07%-376.95K | 34.24%-190.32K | 17.99%-289.4K | -50.53%-352.89K | -114.09%-234.43K | 57.53%-109.5K | -257.82K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 97.74%-36.57K | -7,899.44%-1.62M | 96.25%-20.21K | -203.71%-539.58K | 141.57%520.29K | -395.03%-1.25M | 42.91%424.19K | --296.83K |
| Investing cash flow | ||||||||
| Net PPE purchase and sale | -326.04%-3.03M | -551.60%-710.73K | 75.82%-109.08K | 86.32%-451.17K | -1,399.26%-3.3M | -1,405.20%-219.9K | 95.57%-14.61K | ---329.72K |
| Net intangibles purchase and sale | -57.97%-833.46K | -779.32%-527.59K | ---60K | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | --0 | --0 | ---242.5K | --0 | -119,980.00%-119.88K | --100 | ---- | ---- |
| Net investment product transactions | -516.21%-71.82K | -19.42%17.26K | -98.03%21.41K | 203.47%1.09M | -5,160.00%-1.05M | ---20K | ---- | ---- |
| Repayment of advance payments to other parties and cash income from loans | 54.17%-32.04K | ---69.92K | ---- | ---- | ---- | ---- | ---- | ---- |
| Investing cash flow | -207.16%-3.97M | -230.88%-1.29M | -161.22%-390.16K | 114.26%637.3K | -1,763.54%-4.47M | -1,541.42%-239.8K | 95.57%-14.61K | ---329.72K |
| Financing cash flow | ||||||||
| Net issuance payments of debt | 67.56%-94.52K | 73.35%-291.37K | -227.97%-1.09M | 47.48%854.3K | -73.42%579.25K | 7,888.39%2.18M | -600.13%-27.98K | ---4K |
| Net common stock issuance | -45.71%1.89M | --3.48M | --0 | ---- | --4.6M | ---- | --0 | --100 |
| Increase or decrease of lease financing | -6.22%-362.54K | -6.64%-341.32K | -66.71%-320.06K | -30.97%-191.99K | -225.86%-146.59K | -8.51%-44.99K | -59.31%-41.46K | ---26.02K |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---279K | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | -0.13%-420.44K | -17.63%-419.91K | ---356.98K | --0 | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | ---- | --2.88M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | -80.98%1.01M | 399.68%5.31M | -367.28%-1.77M | -86.07%662.31K | 122.77%4.76M | 3,173.81%2.13M | -132.09%-69.44K | ---29.92K |
| Net cash flow | ||||||||
| Beginning cash position | 41,852.62%2.4M | -99.74%5.73K | 53.29%2.19M | 130.19%1.43M | 2,724.69%619.64K | 93.51%-23.61K | -20.87%-363.74K | ---300.94K |
| Current changes in cash | -224.82%-2.99M | 209.95%2.4M | -386.91%-2.18M | -5.78%760.03K | 25.41%806.69K | 89.11%643.25K | 641.55%340.14K | ---62.81K |
| Effect of exchange rate changes | -107.76%-112 | --1.44K | --0 | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -124.45%-588.06K | 41,852.62%2.4M | -99.74%5.73K | 53.29%2.19M | 130.19%1.43M | 2,724.69%619.64K | 93.51%-23.61K | ---363.74K |
| Free cash flow | -36.54%-3.9M | -551.83%-2.85M | 55.79%-437.98K | 64.32%-990.74K | -88.70%-2.78M | -459.24%-1.47M | 1,345.37%409.58K | ---32.89K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.